Welcome to the upgraded MacSphere! We're putting the finishing touches on it; if you notice anything amiss, email macsphere@mcmaster.ca

Regulation of macrophage SR-BI by lipoproteins and inflammatory stimuli

dc.contributor.advisorTrigatti, Bernardo L.en_US
dc.contributor.advisorIgdoura, Suleiman A.en_US
dc.contributor.advisorTruant, Rayen_US
dc.contributor.authorWang, David Yu Changen_US
dc.contributor.departmentBiochemistryen_US
dc.date.accessioned2014-06-18T16:53:58Z
dc.date.available2014-06-18T16:53:58Z
dc.date.created2011-09-19en_US
dc.date.issued2011-10en_US
dc.description.abstract<p>In atherosclerotic plaques, macrophages ingest modified LDL and turn to foam cells. Others have shown that SR-BI expression levels inversely correlated with cellular cholesterol levels, and is independent of well characterized cholesterol sensing pathways; SREBP and LXR. Thus the mechanism of regulation of SR-BI is unclear. In this study, we showed that treating macrophage with agents known to increase cellular cholesterol levels, namely acLDL, LDL, MβCD:Cholesterol, resulted in reduction in HMGCoAR mRNA and SR-BI expression levels. In contrast, acLDL did not reduce SR-BI mRNA levels in macrophages from acLDL SR-A KO mice, demonstrating that acLDL mediate suppression of SR-BI was dependent on SR-A. Fucoidan, a known competitive inhibitor of acLDL binding to SR-A, and subsequent degradation, also suppressed SR-BI expression levels. Unlike acLDL, however, fucoidan induced mRNA levels corresponding to the pro-inflammatory genes iNOS and IL-6 mRNA levels, and its effects were not altered by the lack of SR-A. Instead, fucoidan mediated stimulation of iNOS and IL-6 and suppression of SR-BI mRNA levels was prevented by an anti-CD14 blocking antibody, demonstrating that the fucoidan mediated effects were dependent on CD14. Interleukin-15, a pro-inflammatory cytokine that binds to a distinct receptor, also induced iNOS and IL-6 mRNA levels and reduced SR-BI expression, suggesting that inflammatory signaling in general can reduce SR-BI expression levels. Treatment of macrophages with the lipoproteins acLDL, LDL or HDL suppressed the induction of iNOS and IL-6 mRNA by fucoidan or IL-15. Macrophages foam cells in an atherosclerotic plaque may have reduced SR-BI due to exposure with modified LDL or inflammatory cytokines or both in an atherosclerotic plaque. SR-BI expression in macrophages protects against atherosclerosis development. Our data suggests that modified lipoproteins as well as inflammatory stimuli suppress SR-BI expression in macrophages and this may contribute to their pro-apoptotic properties.</p>en_US
dc.description.degreeMaster of Science (MSc)en_US
dc.identifier.otheropendissertations/6203en_US
dc.identifier.other7209en_US
dc.identifier.other2245848en_US
dc.identifier.urihttp://hdl.handle.net/11375/11219
dc.subjectAtherosclerosis receptor cholesterol inflammation macrophage lipoproteinen_US
dc.subjectBiochemistryen_US
dc.subjectBiologyen_US
dc.subjectCell Biologyen_US
dc.subjectImmunityen_US
dc.subjectMedical Biochemistryen_US
dc.subjectMedical Cell Biologyen_US
dc.subjectMedical Molecular Biologyen_US
dc.subjectMedical Sciencesen_US
dc.subjectMolecular Biologyen_US
dc.subjectBiochemistryen_US
dc.titleRegulation of macrophage SR-BI by lipoproteins and inflammatory stimulien_US
dc.typethesisen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
fulltext.pdf
Size:
995.53 KB
Format:
Adobe Portable Document Format